vimarsana.com
Home
Live Updates
Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancer : vimarsana.com
Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancer
Targeting Adenosine for Cancer:Challenging Past Assumptions with Next-Generation Small Molecule Inhibitors Thursday, March 9th @ 10:30 am ET WESTPORT, Conn., Feb. 27, 2023 -- Portage Biotech Inc.... | February 27, 2023
Related Keywords
California ,
United States ,
Texas ,
San Francisco ,
Westport ,
Lawrence Fong ,
Gwendolyn Schanker ,
Sumit Subudhi ,
Chuck Padala ,
University Of California ,
Department Of Genitourinary Medical Oncology ,
Linkedin ,
University Of Texas Md Anderson Cancer Center ,
Cancer Immunology Program ,
Md Anderson Cancer Center ,
Portage Biotech Inc ,
Nasdaq ,
Company Annual Report On Form ,
Division Of Hematology Oncology ,
Parker Institute For Cancer Immunotherapy ,
Cancer Immunotherapy Program ,
Department Of Medicine ,
Helen Diller Family Comprehensive Cancer Center ,
Globenewswire Inc ,
Targeting Adenosine ,
Past Assumptions ,
Next Generation Small Molecule ,
Cancer Center ,
Efim Guzik Distinguished Professor ,
Cancer Biology ,
Diller Family Comprehensive Cancer ,
Associate Professor ,
Genitourinary Medical Oncology ,
Portage Biotech ,
Annual Report ,
Portage Biotech Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Targeting ,
Adenosine ,
Or ,
Mast ,
Assumptions ,
Ith ,
Mall ,
Olecule ,
Inhibitors ,
Arch ,
M ,
023 ,
Portage ,
Iotech Prtg Vgg7185a1286 ,
vimarsana.com © 2020. All Rights Reserved.